



Acucela Inc.





































ENGLISH
JAPANESE



HOME

VISION
PIPELINE
IR LIBRARY
COMPANY





FAQs
Contact Us
Privacy Policy
Terms of Use

© 2016 Acucela Inc.
























Acucela Inc. is committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide.





next







VISION
Learn about our vision of restoring sight for millions of people suffering from sight-threatening diseases and conditions.





more info







PIPELINE
Learn about our focus on ophthalmological innovation and breakthrough, and our diverse pipeline portfolio in development.





more info







IR LIBRARY
Access all of our financials and disclosures, as well as corporate presentations and news.





more info







COMPANY
Learn about our leadership team, corporate history and the company, including contact information.





more info
















Management | Acucela Inc.





























ENGLISH
JAPANESE



HOME

VISION
PIPELINE
IR LIBRARY
COMPANY





FAQs
Contact Us
Privacy Policy
Terms of Use

© 2016 Acucela Inc.









COMPANY




Management

Leadership
Ryo Kubota, MD, PhD
Chairman, President and Chief Executive Officer
Prior to founding Acucela in 2002, Dr. Kubota worked in the ophthalmology field, including serving as a faculty member at Keio University and at the University of Washington School of Medicine. Dr. Kubota holds an MD and a PhD in medicine from Keio University. There, he discovered the glaucoma gene, myocilin, a discovery that earned him the Suda Award for his contribution to the field of neurodegenerative retinal disease. He was board certified in ophthalmology by the Japanese Ophthalmological Society in 1996 and is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Japanese Ophthalmology Society, Keio Medical Society, the American Chamber of Commerce in Japan, and the America-Japan Society, Inc. Since 2008, Dr. Kubota has been a director of the Japan-America Society of the State of Washington. He was appointed as Foresight Advisory Group Member, Department of Pharmacology, Case Western Reserve University in 2012. In 2014, Dr. Kubota was appointed to the National Bureau of Asian Research Board of Directors, and a visiting professor at School of Medicine, Keio University. Since 2015, he has been an Advisory member for The Japanese Association of Medical University Network of Technology Transfer.
Lukas Scheibler, PhD
Executive Vice President, R&D
Dr. Scheibler joined Acucela in August 2015 after a 13-year career in research and development, business development and clinical trial management at Novartis. Dr. Scheibler had worked since 2008 at Alcon, a division of Novartis. He most recently was a Vice President in charge of Alcon's Ideation and Technology Evaluation Center, the company's center of excellence in charge of identifying novel technologies that address unmet needs in ophthalmology. Before that, he served as Alcon's Vice President and Global Head of Clinical Trial Management. Dr. Scheibler started work at Novartis headquarters in Switzerland in 2002 as Manager of Global Drug Regulatory Affairs. While he served as VP and Global Head of R&D Alliances at Alcon from 2008 to 2011, the company made several major acquisitions and deals, including the purchase of LenSx Lasers for up to US $744 million, ESBATech for up to US $589 million and a Research Agreement with AstraZeneca for exclusive access to the company's ophthalmology compound library. Dr. Scheibler received a Master's degree in chemistry from University of Basel, Switzerland; a Ph.D. in chemistry from University of Lausanne, Switzerland; and his Postdoctoral Training from Harvard Medical School.
John Gebhart, MBA
Chief Financial Officer; Treasurer and Secretary
Mr. Gebhart joined Acucela in May 2015.  Prior to that, from 2012 to 2015, he was Chief Financial Officer for Qliance Medical Management Inc., a leader in direct primary care services, where he led the company's financial and operations functions during a period of significant growth. From 2004 through 2012 he operated an independent consultancy providing project management and interim executive services to a variety of health services and technology companies including Remote Medical International, Ventripoint, PhysioSonics, Carena, Clarity Health, Nexcura, and DS-IQ.  Mr. Gebhart has worked in emerging health and technology companies for more than 30 years in the roles of CFO, COO, and CEO.  He began his career as a CPA with Ernst & Young and received his MBA from Pepperdine University in Malibu, CA. 
Ted Danse, MBA
Chief Business Officer
Mr. Danse joined Acucela in May 2015. Prior to that he served as President of Replenish, Inc., the developer of a novel MicroPump for retinal drug delivery, for which he was brought in to lead a restructuring, recapitalization and technology transfer to the company's global partner. From 2005 to 2014, Ted served as President and CEO of Neurotech Pharmaceuticals, Inc. In 2006 he transitioned Neurotech from a Paris to a Delaware-based corporate domicile, and restructured and recapitalized the company. Subsequently he was instrumental in the development of two transformational products that address neovascular age-related macular degeneration and glaucoma. Ted's development and commercial experience spans over 30 years in ophthalmology. Previously he was President and CEO of ISTA Pharmaceuticals Inc. and was responsible for taking the Company public (NASDAQ) in 2000. Ted also held various senior positions at Allergan where he was responsible for establishing a high-growth, profitable business operation in Japan, China and the rest of Asia, including the consummation of several successful corporate acquisitions. His early career was spent in business development roles at Coopervision, Bausch & Lomb and Schering-Plough. Ted holds an MBA in International Management from Thunderbird School of Global Management in Glendale, AZ.
Board of Directors
Ryo Kubota, MD, PhD
Representative Executive Officer, Chairman, President and Chief Executive Officer, Kubota Pharmaceutical Holdings Co., Ltd.
Chairman, President and Chief Executive Officer, Acucela Inc.
Shintaro Asako
Chief Executive Officer and Chief Financial Officer, DeNA Corp
Shiro Mita, PhD
President and Chief Executive Officer, M's Science Corporation
Eisaku Nakamura
Corporate Auditor, Koinobori Associates Inc.
Robert Takeuchi
President, RT Consulting, Inc.
Advisory Board
David G. Birch, PhD 
Research Director, Retina Foundation of the Southwest, Director of the Rose-Silverthorne Retinal Degenerations Laboratory, Dallas
Karl G. Csaky, MD, PhD 
T. Boone Pickens Senior Scientist, Director, Harrington Molecular Laboratory, Member, Texas Retina Associates
Pravin U. Dugel, MD 
Managing Partner, Retinal Consultants of Arizona
Dean Eliott, MD 
Co-Director, Mass Eye & Ear, Vitrectomy Course, Massachusetts Eye and Ear Infirmary
Jeffrey S. Heier, MD 
Vitreoretinal Specialist, Ophthalmic Consultants of Boston
Frank G. Holz, MD 
Chairman & Professor of the Department of Ophthalmology, University of Bonn, Germany
Anne S. Lindblad, PhD 
Executive Vice President, The EMMES Corporation
Carl D. Regillo, MD, FACS 
Director, Retina Service, Wills Eye Institute-Mid-Atlantic Retina; Professor, Ophthalmology, Thomas Jefferson University School of Medicine
Philip J. Rosenfeld, MD, PhD 
Professor, Bascom Palmer Eye Institute University of Miami Miller School of Medicine, and Bascom Palmer Eye Institute Palm Beach Gardens University of Miami Miller School of Medicine
Gaurav K. Shah, MD, PhD 
Professor of Clinical Ophthalmology & Visual Sciences; Director of Vitreoretinal Fellowship Program, Washington University School of Medicine
Michael A. Singer, MD 
Vitreoretinal Surgeon and Managing Partner, Medical Center Ophthalmology Associates; Clinical Assistant Professor, University of Texas Health Center
Janet S. Sunness, MD 
Medical Director of Hoover Rehabilitation Services for Low Vision and Blindness, Greater Baltimore Medical Center
Kang Zhang, MD, PhD 
Professor of Ophthalmology & Human Genetics, Shiley Eye Center, University of California San Diego
Eberhart Zrenner, MD 
Professor, Department of Ophthalmology, Director of the Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Germany















Acucela Inc. - Product Pipeline Review - 2015





















































Purchase this report

Acucela Inc. - Product Pipeline Review - 2015




Published
Pages
Publisher
Report code


Mar 2015
27
Global Markets Direct
ASDR-189302






Published: Mar 2015  -  
    Pages : 27  -  
    Publisher : Global Markets Direct  -  
    Report code : ASDR-189302	
	
















DescriptionDesc.
ContentCont.
Figures / TablesFiguresFig.

Free SampleSample



 Acucela Inc. - Product Pipeline Review - 2015SummaryThe new report, 'Acucela Inc. - Product Pipeline Review - 2015’, provides an overview of the Acucela Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.The new report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the report's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the new report's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.Scope The report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Acucela Inc.’s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement  Latest news and deals relating to the Acucela Inc.’s pipeline productsReasons to buy Evaluate Acucela Inc.’s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Acucela Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Acucela Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues






Purchase this report





US $
Euro €
GBP £









						1-User PDF
                         

US$ 1,500.00





    						Site PDF
                         

US$ 3,000.00





    						Enterprise PDF
                         

US$ 4,500.00



 Add to Cart








 
                                Lowest Price Guarantee



License and delivery.



Order process.







   646-513-4192       Question about this report?  














This report can be of interest as well:
Needles Market - Global Forecast to 2022 

Published: June, 2017 | Report code: ASDR-398331




    Mark your calendar: 4th Life Science Knowledge Management Summit 09 August - 10 August, 2017Boston, United States   





























Acucela Inc. - Product Pipeline Review - 2015























































  info@wiseguyreports.com  |   
 Chat with us   |    +1 (339) 368 6938 (US)  |     +44 208 133 9349 (UK) 



 Login    Register 






















Home


Report Categories







Premium Reports

Access to 600000+ Premium Reports











  
                                Aerospace & Defense
                              









  
                                Agri & Food
                              









  
                                Automotive
                              









  
                                Basic Materials
                              











  
                                Consumer Goods & Retail
                              









  
                                Energy
                              









  
                                Life Sciences
                              









  
                                Manufacturing & Construction
                              











  
                                Services
                              









  
                                Telecom & IT
                              









  
                                Education
                              









  
                                Security & Intelligence Systems
                              











  
                                Technology
                              









  
                                Company Reports
                              










Report Categories 










Aerospace & Defense
                





Agri & Food
                





Automotive
                





Basic Materials
                







Consumer Goods & Retail
                





Energy
                





Life Sciences
                





Manufacturing & Construction
                







Services
                





Telecom & IT
                





Education
                





Security & Intelligence Systems
                







Technology
                





Company Reports
                








Publisher
Knowledgestore

Countries 
              


Browse by Country
Browse by Continent
Browse by Group / Region



 Conferences
              


Upcoming Conferences
Seminars




 Conferences
              


Upcoming Conferences
Seminars




Countries 

Browse by Country
Browse by Continent
Browse by Group / Region



News & Blog

 Press Release
Blog



News & Blogs

 Press Release
Blogs


FAQs

About Us

About Our Company
Our Team
Life At WGR


Careers
Contact Us











                                         There are no items currently in your basket.
                                     













There are no items currently in your basket!














  




































Search 
                






 














Home
All Reports
Acucela Inc. - Product Pipeline Review - 2015









 


  Acucela Inc. - Product Pipeline Review - 2015


WGR41615
11 
                  March, 2015 
Global
27 pages 
Global Markets Direct






















Description




Table of Content




Sample Report




Enquiry before buy




Related Reports





Acucela Inc. - Product Pipeline Review - 2015SummaryGlobal Markets Direct’s, ‘Acucela Inc. - Product Pipeline Review - 2015’, provides an overview of the Acucela Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.Scope- The report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiaries- The report reviews current pipeline of Acucela Inc.’s human therapeutic division and enlists all their major and minor projects- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio- The report summarizes all the dormant and discontinued pipeline projects- Latest company statement - Latest news and deals relating to the Acucela Inc.’s pipeline productsReasons to buy- Evaluate Acucela Inc.’s strategic position with total access to detailed information on its product pipeline- Assess the growth potential of Acucela Inc. in its therapy areas of focus- Identify new drug targets and therapeutic classes in the Acucela Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps- Develop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunities- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope- Explore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areas- Avoid Intellectual Property Rights related issues


Table of ContentsTable of Contents 2List of Tables 3List of Figures 3Acucela Inc. Snapshot 4Acucela Inc. Overview 4Key Information 4Key Facts 4Acucela Inc. - Research and Development Overview 5Key Therapeutic Areas 5Acucela Inc. - Pipeline Review 7Pipeline Products by Stage of Development 7Pipeline Products - Monotherapy 8Pipeline Products - Partnered Products 9Partnered Products/Combination Treatment Modalities 10Acucela Inc. - Pipeline Products Glance 11Acucela Inc. - Late Stage Pipeline Products 11Phase III Products/Combination Treatment Modalities 11Acucela Inc. - Early Stage Pipeline Products 12Preclinical Products/Combination Treatment Modalities 12Acucela Inc. - Drug Profiles 13emixustat hydrochloride 13Product Description 13Mechanism of Action 13R&D Progress 13Small Molecule for Retinitis Pigmentosa 15Product Description 15Mechanism of Action 15R&D Progress 15Small Molecule for Retinopathy of Prematurity 16Product Description 16Mechanism of Action 16R&D Progress 16Small Molecule for Stargardt Disease 17Product Description 17Mechanism of Action 17R&D Progress 17Acucela Inc. - Pipeline Analysis 18Acucela Inc. - Pipeline Products by Target 18Acucela Inc. - Pipeline Products by Route of Administration 19Acucela Inc. - Pipeline Products by Molecule Type 20Acucela Inc. - Pipeline Products by Mechanism of Action 21Acucela Inc. - Recent Pipeline Updates 22Acucela Inc. - Dormant Projects 24Acucela Inc. - Locations And Subsidiaries 25Head Office 25Other Locations & Subsidiaries 25Appendix 26Methodology 26Coverage 26Secondary Research 26Primary Research 26Expert Panel Validation 26Contact Us 26Disclaimer 27List of TablesAcucela Inc., Key Information 4Acucela Inc., Key Facts 4Acucela Inc. - Pipeline by Indication, 2015 6Acucela Inc. - Pipeline by Stage of Development, 2015 7Acucela Inc. - Monotherapy Products in Pipeline, 2015 8Acucela Inc. - Partnered Products in Pipeline, 2015 9Acucela Inc. - Partnered Products/ Combination Treatment Modalities, 2015 10Acucela Inc. - Phase III, 2015 11Acucela Inc. - Preclinical, 2015 12Acucela Inc. - Pipeline by Target, 2015 18Acucela Inc. - Pipeline by Route of Administration, 2015 19Acucela Inc. - Pipeline by Molecule Type, 2015 20Acucela Inc. - Pipeline Products by Mechanism of Action, 2015 21Acucela Inc. - Recent Pipeline Updates, 2015 22Acucela Inc. - Dormant Developmental Projects,2015 24Acucela Inc., Other Locations 25List of FiguresAcucela Inc. - Pipeline by Top 10 Indication, 2015 6Acucela Inc. - Pipeline by Stage of Development, 2015 7Acucela Inc. - Monotherapy Products in Pipeline, 2015 8Acucela Inc. - Partnered Products in Pipeline, 2015 9Acucela Inc. - Pipeline by Top 10 Target, 2015 18Acucela Inc. - Pipeline by Top 10 Route of Administration, 2015 19Acucela Inc. - Pipeline by Top 10 Molecule Type, 2015 20Acucela Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 21







                                Request a Sample Report
                                




Name:*










Email:*


(Optional: Request you to please fill in your Corporate Email-ID)



Job Title:*





Company:*





Phone No:*





Your Country:*

--select country--
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodja
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo-Brazzaville
Congo-Kinshasa
Cook Islands
Costa Rica
Cote d"Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland (Malvinas)
Faroes
Fiji
Finland
France
French-Guiana
Tahiti(French Polinesia)
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Vatican City
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Norfolk
Northern Mariana
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Lucia
Saint Pierre and Miquelon
St Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands British
Virgin Islands US
Wales
Western Sahara
Yemen
Zambia
Zimbabwe
Timor-Leste
Curacao
St Kitts & Nevis
Sint Maarten
Guernsey
Isle of Man
Jersey
Niue
Montenegro



Do you have any Specific field of Interest?*

















Confirm


 








Make an enquiry before buying this Report




Name:*










Email:*


(Optional: Request you to please fill in your Corporate Email-ID)



Job Title:*





Company:*





Phone No:*





Your Country:*

--select country--
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodja
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Colombia
Comoros
Congo-Brazzaville
Congo-Kinshasa
Cook Islands
Costa Rica
Cote d"Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland (Malvinas)
Faroes
Fiji
Finland
France
French-Guiana
Tahiti(French Polinesia)
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Vatican City
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Norfolk
Northern Mariana
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Lucia
Saint Pierre and Miquelon
St Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands British
Virgin Islands US
Wales
Western Sahara
Yemen
Zambia
Zimbabwe
Timor-Leste
Curacao
St Kitts & Nevis
Sint Maarten
Guernsey
Isle of Man
Jersey
Niue
Montenegro



Your Enquiry*

















Confirm


 
















Purchase this Market Research Report







 USD




 GBP




 EURO




 YEN




 INR







                        1-user PDF
                         
                          $1,500.00
                        

 
                        Site PDF 
                         
                          $3,000.00
                        

 
                        Enterprise PDF 
                         
                          $4,500.00
                        





  1-user PDF
  
 
    1,147.50
   

 
  Site PDF 
  
 
  2,295.00
  

 
  Enterprise PDF 
  
 
  3,442.50
  





  1-user PDF
  
 
    1,282.20
   

 
  Site PDF 
  
 
  2,564.40
  

 
  Enterprise PDF 
  
 
  3,846.60
  





  1-user PDF
  
 
    167,206.50
   

 
  Site PDF 
  
 
  334,413.00
  

 
  Enterprise PDF 
  
 
  501,619.50
  





  1-user PDF
  
 
    96,540.00
   

 
  Site PDF 
  
 
  193,080.00
  

 
  Enterprise PDF 
  
 
  289,620.00
  









Add To Cart
BUY NOW





 















  Email Report


  Sample Report




  Save Page


  Any Questions




  Download information


  Check Discount




  Download Order Form









  Email Report


  Sample Report




  Save Page


  Any Questions




  Download information


  Check Discount




  Download Order Form






Contact Us










Akash Anand
Domain Head Business Development
sales@wiseguyreports.com
+1 (646) 843 9312 (US)
+44 208 133 9349 (UK)













Rishabh Arora
Domain Head Business Development
sales@wiseguyreports.com
+44-208-133-9346













Abu Koshy
Domain Head Business Development
sales@wiseguyreports.com
+1 339 368 6938










Related Reports








                  ×
              
Tell a friend about this report 




Your Name:*





Your Email:*





Friend's Name:*





Friend's Email:*





Your Enquiry*









Send


 






















































Acucela Inc. - Product Pipeline Review - 2015



















+49 322 210 92714
                                    (GMT OFFICE HOURS)
                                

+1-855-465-4651
                                    (US/CAN TOLL FREE)
                                

+1-386-310-3803
                                    (US OFFICE NO)
                                
































Home
Categories
Become Publisher
News
About Us
Contact Us



























-Select Category-
Consumer Goods
Food & Beverage
Heavy Industry
Life Sciences
Marketing & Market Research
Public Sector
Service Industries
Technology & Media
Semiconductor
Chemical and Materials
Metallurgical
Market Research




Search












Home >> Life Sciences >> Pharmaceuticals >> General Pharmaceuticals


Acucela Inc. - Product Pipeline Review - 2015



Published: Mar-2015 | Format: PDF | Global Markets Direct | Number of pages: 27 | Code: MRS - 11303



Report Details
Table Of Content
Inquiry For Buying
Request Sample




 
Global Markets Directs, Acucela Inc. Product Pipeline Review 2015, provides an overview of the Acucela Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope
 
The report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Acucela Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Acucela Inc.s pipeline products
 
Reasons to buy
 
Evaluate Acucela Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Acucela Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Acucela Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues



Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Acucela Inc. Snapshot 4
Acucela Inc. Overview 4
Key Information 4
Key Facts 4
Acucela Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Acucela Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Acucela Inc. - Pipeline Products Glance 11
Acucela Inc. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Acucela Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Acucela Inc. - Drug Profiles 13
emixustat hydrochloride 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecule for Retinitis Pigmentosa 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecule for Retinopathy of Prematurity 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecule for Stargardt Disease 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Acucela Inc. - Pipeline Analysis 18
Acucela Inc. - Pipeline Products by Target 18
Acucela Inc. - Pipeline Products by Route of Administration 19
Acucela Inc. - Pipeline Products by Molecule Type 20
Acucela Inc. - Pipeline Products by Mechanism of Action 21
Acucela Inc. - Recent Pipeline Updates 22
Acucela Inc. - Dormant Projects 24
Acucela Inc. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
 
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 26
Disclaimer 27

 
List of Tables
 
Acucela Inc., Key Information 4
Acucela Inc., Key Facts 4
Acucela Inc. - Pipeline by Indication, 2015 6
Acucela Inc. - Pipeline by Stage of Development, 2015 7
Acucela Inc. - Monotherapy Products in Pipeline, 2015 8
Acucela Inc. - Partnered Products in Pipeline, 2015 9
Acucela Inc. - Partnered Products/ Combination Treatment Modalities, 2015 10
Acucela Inc. - Phase III, 2015 11
Acucela Inc. - Preclinical, 2015 12
Acucela Inc. - Pipeline by Target, 2015 18
Acucela Inc. - Pipeline by Route of Administration, 2015 19
Acucela Inc. - Pipeline by Molecule Type, 2015 20
Acucela Inc. - Pipeline Products by Mechanism of Action, 2015 21
Acucela Inc. - Recent Pipeline Updates, 2015 22
Acucela Inc. - Dormant Developmental Projects,2015 24
Acucela Inc., Other Locations 25

 
List of Figures
 
Acucela Inc. - Pipeline by Top 10 Indication, 2015 6
Acucela Inc. - Pipeline by Stage of Development, 2015 7
Acucela Inc. - Monotherapy Products in Pipeline, 2015 8
Acucela Inc. - Partnered Products in Pipeline, 2015 9
Acucela Inc. - Pipeline by Top 10 Target, 2015 18
Acucela Inc. - Pipeline by Top 10 Route of Administration, 2015 19
Acucela Inc. - Pipeline by Top 10 Molecule Type, 2015 20
Acucela Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 21


Inquiry For Buying

Please fill your details below, to inquire about this report:
* Indicates required fields






 





Name:






Email:






Phone:






Name of company:






Title/Designation:






Country Name:

-Select Country-
ANDORRA
UNITED ARAB EMIRATES
AFGHANISTAN
ANTIGUA AND BARBUDA
ANGUILLA
ALBANIA
ARMENIA
ANGOLA
ANTARCTICA
ARGENTINA
AMERICAN SAMOA
AUSTRIA
AUSTRALIA
ARUBA
ÅLAND ISLANDS
AZERBAIJAN
BOSNIA AND HERZEGOVINA
BARBADOS
BANGLADESH
BELGIUM
BURKINA FASO
BULGARIA
BAHRAIN
BURUNDI
BENIN
SAINT BARTHÉLEMY
BERMUDA
BRUNEI DARUSSALAM
BOLIVIA, PLURINATIONAL STATE OF
BONAIRE, SINT EUSTATIUS AND SABA
BRAZIL
BAHAMAS
BHUTAN
BOUVET ISLAND
BOTSWANA
BELARUS
BELIZE
CANADA
COCOS (KEELING) ISLANDS
CONGO, THE DEMOCRATIC REPUBLIC OF THE
CENTRAL AFRICAN REPUBLIC
CONGO
SWITZERLAND
CÔTE D'IVOIRE
COOK ISLANDS
CHILE
CAMEROON
CHINA
COLOMBIA
COSTA RICA
CUBA
CAPE VERDE
CURAÇAO
CHRISTMAS ISLAND
CYPRUS
CZECH REPUBLIC
GERMANY
DJIBOUTI
DENMARK
DOMINICA
DOMINICAN REPUBLIC
ALGERIA
ECUADOR
ESTONIA
EGYPT
WESTERN SAHARA
ERITREA
SPAIN
ETHIOPIA
FINLAND
FIJI
FALKLAND ISLANDS (MALVINAS)
MICRONESIA, FEDERATED STATES OF
FAROE ISLANDS
FRANCE
GABON
UNITED KINGDOM
GRENADA
GEORGIA
FRENCH GUIANA
GUERNSEY
GHANA
GIBRALTAR
GREENLAND
GAMBIA
GUINEA
GUADELOUPE
EQUATORIAL GUINEA
GREECE
SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
GUATEMALA
GUAM
GUINEA-BISSAU
GUYANA
HONG KONG
HEARD ISLAND AND MCDONALD ISLANDS
HONDURAS
CROATIA
HAITI
HUNGARY
INDONESIA
IRELAND
ISRAEL
ISLE OF MAN
INDIA
BRITISH INDIAN OCEAN TERRITORY
IRAQ
IRAN, ISLAMIC REPUBLIC OF
ICELAND
ITALY
JERSEY
JAMAICA
JORDAN
JAPAN
KENYA
KYRGYZSTAN
CAMBODIA
KIRIBATI
COMOROS
SAINT KITTS AND NEVIS
KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
KOREA, REPUBLIC OF
KUWAIT
CAYMAN ISLANDS
KAZAKHSTAN
LAO PEOPLE'S DEMOCRATIC REPUBLIC
LEBANON
SAINT LUCIA
LIECHTENSTEIN
SRI LANKA
LIBERIA
LESOTHO
LITHUANIA
LUXEMBOURG
LATVIA
LIBYA
MOROCCO
MONACO
MOLDOVA, REPUBLIC OF
MONTENEGRO
SAINT MARTIN (FRENCH PART)
MADAGASCAR
MARSHALL ISLANDS
MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF
MALI
MYANMAR
MONGOLIA
MACAO
NORTHERN MARIANA ISLANDS
MARTINIQUE
MAURITANIA
MONTSERRAT
MALTA
MAURITIUS
MALDIVES
MALAWI
MEXICO
MALAYSIA
MOZAMBIQUE
NAMIBIA
NEW CALEDONIA
NIGER
NORFOLK ISLAND
NIGERIA
NICARAGUA
NETHERLANDS
NORWAY
NEPAL
NAURU
NIUE
NEW ZEALAND
OMAN
PANAMA
PERU
FRENCH POLYNESIA
PAPUA NEW GUINEA
PHILIPPINES
PAKISTAN
POLAND
SAINT PIERRE AND MIQUELON
PITCAIRN
PUERTO RICO
PALESTINIAN, STATE OF
PORTUGAL
PALAU
PARAGUAY
QATAR
RÉUNION
ROMANIA
SERBIA
RUSSIAN FEDERATION
RWANDA
SAUDI ARABIA
SOLOMON ISLANDS
SEYCHELLES
SUDAN
SWEDEN
SINGAPORE
SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA
SLOVENIA
SVALBARD AND JAN MAYEN
SLOVAKIA
SIERRA LEONE
SAN MARINO
SENEGAL
SOMALIA
SURINAME
SOUTH SUDAN
SAO TOME AND PRINCIPE
EL SALVADOR
SINT MAARTEN (DUTCH PART)
SYRIAN ARAB REPUBLIC
SWAZILAND
TURKS AND CAICOS ISLANDS
CHAD
FRENCH SOUTHERN TERRITORIES
TOGO
THAILAND
TAJIKISTAN
TOKELAU
TIMOR-LESTE
TURKMENISTAN
TUNISIA
TONGA
TURKEY
TRINIDAD AND TOBAGO
TUVALU
TAIWAN, PROVINCE OF CHINA
TANZANIA, UNITED REPUBLIC OF
UKRAINE
UGANDA
UNITED STATES MINOR OUTLYING ISLANDS
UNITED STATES
URUGUAY
UZBEKISTAN
HOLY SEE (VATICAN CITY STATE)
SAINT VINCENT AND THE GRENADINES
VENEZUELA, BOLIVARIAN REPUBLIC OF
VIRGIN ISLANDS, BRITISH
VIRGIN ISLANDS, U.S.
VIET NAM
VANUATU
WALLIS AND FUTUNA
SAMOA
YEMEN
MAYOTTE
SOUTH AFRICA
ZAMBIA
ZIMBABWE





How can we help you?











Refresh



captcha:





 


Submit







Request Sample

Please fill your details below, to receive sample report:
* Indicates required fields






 





Name:






Email:






Phone:






Name of company:






Title/Designation:






Country Name:

-Select Country-
ANDORRA
UNITED ARAB EMIRATES
AFGHANISTAN
ANTIGUA AND BARBUDA
ANGUILLA
ALBANIA
ARMENIA
ANGOLA
ANTARCTICA
ARGENTINA
AMERICAN SAMOA
AUSTRIA
AUSTRALIA
ARUBA
ÅLAND ISLANDS
AZERBAIJAN
BOSNIA AND HERZEGOVINA
BARBADOS
BANGLADESH
BELGIUM
BURKINA FASO
BULGARIA
BAHRAIN
BURUNDI
BENIN
SAINT BARTHÉLEMY
BERMUDA
BRUNEI DARUSSALAM
BOLIVIA, PLURINATIONAL STATE OF
BONAIRE, SINT EUSTATIUS AND SABA
BRAZIL
BAHAMAS
BHUTAN
BOUVET ISLAND
BOTSWANA
BELARUS
BELIZE
CANADA
COCOS (KEELING) ISLANDS
CONGO, THE DEMOCRATIC REPUBLIC OF THE
CENTRAL AFRICAN REPUBLIC
CONGO
SWITZERLAND
CÔTE D'IVOIRE
COOK ISLANDS
CHILE
CAMEROON
CHINA
COLOMBIA
COSTA RICA
CUBA
CAPE VERDE
CURAÇAO
CHRISTMAS ISLAND
CYPRUS
CZECH REPUBLIC
GERMANY
DJIBOUTI
DENMARK
DOMINICA
DOMINICAN REPUBLIC
ALGERIA
ECUADOR
ESTONIA
EGYPT
WESTERN SAHARA
ERITREA
SPAIN
ETHIOPIA
FINLAND
FIJI
FALKLAND ISLANDS (MALVINAS)
MICRONESIA, FEDERATED STATES OF
FAROE ISLANDS
FRANCE
GABON
UNITED KINGDOM
GRENADA
GEORGIA
FRENCH GUIANA
GUERNSEY
GHANA
GIBRALTAR
GREENLAND
GAMBIA
GUINEA
GUADELOUPE
EQUATORIAL GUINEA
GREECE
SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
GUATEMALA
GUAM
GUINEA-BISSAU
GUYANA
HONG KONG
HEARD ISLAND AND MCDONALD ISLANDS
HONDURAS
CROATIA
HAITI
HUNGARY
INDONESIA
IRELAND
ISRAEL
ISLE OF MAN
INDIA
BRITISH INDIAN OCEAN TERRITORY
IRAQ
IRAN, ISLAMIC REPUBLIC OF
ICELAND
ITALY
JERSEY
JAMAICA
JORDAN
JAPAN
KENYA
KYRGYZSTAN
CAMBODIA
KIRIBATI
COMOROS
SAINT KITTS AND NEVIS
KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
KOREA, REPUBLIC OF
KUWAIT
CAYMAN ISLANDS
KAZAKHSTAN
LAO PEOPLE'S DEMOCRATIC REPUBLIC
LEBANON
SAINT LUCIA
LIECHTENSTEIN
SRI LANKA
LIBERIA
LESOTHO
LITHUANIA
LUXEMBOURG
LATVIA
LIBYA
MOROCCO
MONACO
MOLDOVA, REPUBLIC OF
MONTENEGRO
SAINT MARTIN (FRENCH PART)
MADAGASCAR
MARSHALL ISLANDS
MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF
MALI
MYANMAR
MONGOLIA
MACAO
NORTHERN MARIANA ISLANDS
MARTINIQUE
MAURITANIA
MONTSERRAT
MALTA
MAURITIUS
MALDIVES
MALAWI
MEXICO
MALAYSIA
MOZAMBIQUE
NAMIBIA
NEW CALEDONIA
NIGER
NORFOLK ISLAND
NIGERIA
NICARAGUA
NETHERLANDS
NORWAY
NEPAL
NAURU
NIUE
NEW ZEALAND
OMAN
PANAMA
PERU
FRENCH POLYNESIA
PAPUA NEW GUINEA
PHILIPPINES
PAKISTAN
POLAND
SAINT PIERRE AND MIQUELON
PITCAIRN
PUERTO RICO
PALESTINIAN, STATE OF
PORTUGAL
PALAU
PARAGUAY
QATAR
RÉUNION
ROMANIA
SERBIA
RUSSIAN FEDERATION
RWANDA
SAUDI ARABIA
SOLOMON ISLANDS
SEYCHELLES
SUDAN
SWEDEN
SINGAPORE
SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA
SLOVENIA
SVALBARD AND JAN MAYEN
SLOVAKIA
SIERRA LEONE
SAN MARINO
SENEGAL
SOMALIA
SURINAME
SOUTH SUDAN
SAO TOME AND PRINCIPE
EL SALVADOR
SINT MAARTEN (DUTCH PART)
SYRIAN ARAB REPUBLIC
SWAZILAND
TURKS AND CAICOS ISLANDS
CHAD
FRENCH SOUTHERN TERRITORIES
TOGO
THAILAND
TAJIKISTAN
TOKELAU
TIMOR-LESTE
TURKMENISTAN
TUNISIA
TONGA
TURKEY
TRINIDAD AND TOBAGO
TUVALU
TAIWAN, PROVINCE OF CHINA
TANZANIA, UNITED REPUBLIC OF
UKRAINE
UGANDA
UNITED STATES MINOR OUTLYING ISLANDS
UNITED STATES
URUGUAY
UZBEKISTAN
HOLY SEE (VATICAN CITY STATE)
SAINT VINCENT AND THE GRENADINES
VENEZUELA, BOLIVARIAN REPUBLIC OF
VIRGIN ISLANDS, BRITISH
VIRGIN ISLANDS, U.S.
VIET NAM
VANUATU
WALLIS AND FUTUNA
SAMOA
YEMEN
MAYOTTE
SOUTH AFRICA
ZAMBIA
ZIMBABWE





How can we help you?











Refresh



captcha:





 


Submit











Related Reports


Global Tinnitus Drug Market Professional Survey Report 2017

Jul-2017 | QY Research | Pages : 101 | Code : MRS-151339 | 3500
                    
This report studies Tinnitus Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.  This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - Actavis - Teva - Mylan - Sun Pharmaceutical  Read more




Global and China Laboratory Ventilators Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 109 | Code : MRS-151334 | 2700
                    
The Global and China Laboratory Ventilators Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Laboratory Ventilators industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Laboratory Ventilators market study provides comprehensive data which enh Read more




United States Laboratory Ventilators Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 140 | Code : MRS-151333 | 3700
                    
The United States Laboratory Ventilators Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Laboratory Ventilators industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Laboratory Ventilators market study provides comprehensive data which enhanc Read more




Europe Laboratory Ventilators Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 134 | Code : MRS-151332 | 3800
                    
The Europe Laboratory Ventilators Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Laboratory Ventilators industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Laboratory Ventilators market study provides comprehensive data which enhances the  Read more




China Laboratory Ventilators Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 118 | Code : MRS-151331 | 3100
                    
The China Laboratory Ventilators Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Laboratory Ventilators industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Laboratory Ventilators market study provides comprehensive data which enhances the u Read more




Global Laboratory Ventilators Market Professional Survey Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 133 | Code : MRS-151330 | 3400
                    
This report studies Laboratory Ventilators in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Harvard Apparatus Parr Instrument Harvard Bioscience Columbus Instruments company 8 company 9 ... B Read more




Global Laboratory Ventilators Sales Market Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 110 | Code : MRS-151329 | 3800
                    
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. The Read more




Global Laboratory Ventilators Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 117 | Code : MRS-151328 | 2800
                    
The Global Laboratory Ventilators Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Laboratory Ventilators industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Laboratory Ventilators market study provides comprehensive data which enhances the  Read more




Global and China Medical Bone Densitometers Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 139 | Code : MRS-151327 | 2700
                    
The Global and China Medical Bone Densitometers Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Medical Bone Densitometers industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Medical Bone Densitometers market study provides comprehensive da Read more




United States Medical Bone Densitometers Market Research Report Forecast 2017-2021

Mar-2017 | S&P Consulting | Pages : 105 | Code : MRS-151326 | 3700
                    
The United States Medical Bone Densitometers Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Medical Bone Densitometers industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Medical Bone Densitometers market study provides comprehensive data  Read more








Payment Mode




Single User  | $(USD)1500








Multi User | $(USD)3000








Corporate User  | $(USD)4500













Latest Report


2017 Global Non-Slip Epoxy Glass Flake Paint Market Research Report


2017 Global Parking Sensors Market Research Report


2017 Global Nitrogen Oxide Sensor Market Research Report


2017 Global Nuclear Density Gauge Market Research Report


2017 Global Automotive Interior Materials Market Research Report

View More



Latest News


Global Chitosan Market Set for Rapid Growth, To Reach USD 4.74 Billion by 2021

Zion Market Research has published a new report titled Chitosan Market for Water Treatment, Biomed



Development of e-commerce to Reshape Global Mobile Hotspot Router Market

Mobile hotspot is a popular feature on smart phones that provide wireless internet access on many 



Global Carotenoids Market Is Expected To Reach Around USD 1.52 Billion in 2021

Zion Market Research has published a new report titled Carotenoids Market by Type (Astaxanthin, Be



Soaring Demand from Food & Beverages Industry to Act as Prime Driving for Ascorbic Acid Market, Reports Zion Market Research

Ascorbic acid is extensively available in nature, mostly rich in leafy vegetables and fresh fruits



Global Energy Management System (EMS) Market Is Set for a Rapid Growth and is Expected to Reach USD 63,161.5 million by 2021

Zion Market Research has published a new report titled Energy Management System Market (EMS) by So


View More














Single User | $(USD)1500
View Pricing 













Find Help

How to Order
Disclaimer 
FAQs
Return Policy
Sitemap



Our Company

About Us
Terms and Conditions
Privacy Policy



We accept the following payment methods






© 2016 - 2017 Market Research Store - Market Research Reports 












Acucela Inc. - Product Pipeline Review - 2015































| Compare 
About Us | 
Contact Us






Home
Research Category
Publisher List
Custom Research
Cart
Compare



Research Category
User Guide
Policies
Contact Us
About us
Site Map











Home > Market Research Report  > Pharmaceutical > Pharmaceutical Companies > Pharma Info









Market Research Report
Acucela Inc. - Product Pipeline Review - 2015



Published by
Global Markets Direct
Product code
192434


Published
March 11, 2015
Content info
27 Pages 


Price








USD 1500

PDF by E-mail (Single user license)





USD 3000

PDF by E-mail (Site license)





USD 4500

PDF by E-mail (Global license)
























Acucela Inc. - Product Pipeline Review - 2015



Published: March 11, 2015
Content info: 27 Pages














Description

Summary
Global Markets Direct's, 'Acucela Inc. - Product Pipeline Review - 2015', provides an overview of the Acucela Inc.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope

 The report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiaries
 The report reviews current pipeline of Acucela Inc.'s human therapeutic division and enlists all their major and minor projects
 The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
 Special feature on out-licensed and partnered product portfolio
 The report summarizes all the dormant and discontinued pipeline projects
 Latest company statement
 Latest news and deals relating to the Acucela Inc.'s pipeline products

Reasons to buy

 Evaluate Acucela Inc.'s strategic position with total access to detailed information on its product pipeline
 Assess the growth potential of Acucela Inc. in its therapy areas of focus
 Identify new drug targets and therapeutic classes in the Acucela Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
 Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
 Develop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunities
 Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc.
 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Explore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areas
 Avoid Intellectual Property Rights related issues




Table of Contents
Product Code: GMDHC06847CDBTable of Contents

Table of Contents 

List of Tables 
List of Figures 

Acucela Inc. Snapshot 

Acucela Inc. Overview 
Key Information 
Key Facts 

Acucela Inc. - Research and Development Overview 

Key Therapeutic Areas 

Acucela Inc. - Pipeline Review 

Pipeline Products by Stage of Development 
Pipeline Products - Monotherapy 
Pipeline Products - Partnered Products 

Partnered Products/Combination Treatment Modalities 


Acucela Inc. - Pipeline Products Glance 

Acucela Inc. - Late Stage Pipeline Products 

Phase III Products/Combination Treatment Modalities 

Acucela Inc. - Early Stage Pipeline Products 

Preclinical Products/Combination Treatment Modalities 


Acucela Inc. - Drug Profiles 

emixustat hydrochloride 

Product Description 
Mechanism of Action 
R&D Progress

Small Molecule for Retinitis Pigmentosa 

Product Description 
Mechanism of Action 
R&D Progress

Small Molecule for Retinopathy of Prematurity 

Product Description 
Mechanism of Action 
R&D Progress

Small Molecule for Stargardt Disease 

Product Description 
Mechanism of Action 
R&D Progress


Acucela Inc. - Pipeline Analysis 

Acucela Inc. - Pipeline Products by Target 
Acucela Inc. - Pipeline Products by Route of Administration 
Acucela Inc. - Pipeline Products by Molecule Type 
Acucela Inc. - Pipeline Products by Mechanism of Action 

Acucela Inc. - Recent Pipeline Updates 
Acucela Inc. - Dormant Projects 
Acucela Inc. - Locations And Subsidiaries 

Head Office 
Other Locations & Subsidiaries 

Appendix 

Methodology 
Coverage 
Secondary Research 
Primary Research 
Expert Panel Validation 
Contact Us 
Disclaimer 


List of Tables

Acucela Inc., Key Information 
Acucela Inc., Key Facts 
Acucela Inc. - Pipeline by Indication, 2015 
Acucela Inc. - Pipeline by Stage of Development, 2015 
Acucela Inc. - Monotherapy Products in Pipeline, 2015 
Acucela Inc. - Partnered Products in Pipeline, 2015 
Acucela Inc. - Partnered Products/ Combination Treatment Modalities, 2015 
Acucela Inc. - Phase III, 2015 
Acucela Inc. - Preclinical, 2015 
Acucela Inc. - Pipeline by Target, 2015 
Acucela Inc. - Pipeline by Route of Administration, 2015 
Acucela Inc. - Pipeline by Molecule Type, 2015 
Acucela Inc. - Pipeline Products by Mechanism of Action, 2015 
Acucela Inc. - Recent Pipeline Updates, 2015 
Acucela Inc. - Dormant Developmental Projects,2015 
Acucela Inc., Other Locations 

List of Figures

Acucela Inc. - Pipeline by Top 10 Indication, 2015 
Acucela Inc. - Pipeline by Stage of Development, 2015 
Acucela Inc. - Monotherapy Products in Pipeline, 2015 
Acucela Inc. - Partnered Products in Pipeline, 2015 
Acucela Inc. - Pipeline by Top 10 Target, 2015 
Acucela Inc. - Pipeline by Top 10 Route of Administration, 2015 
Acucela Inc. - Pipeline by Top 10 Molecule Type, 2015 
Acucela Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 








Phone


Int'l: +1-860-674-8796
TollFree(US): +1-866-353-3335
Europe: +32-2-535-7543
Asia: +65-6223-2436


New for 2017 !

GII now purchases any market research reports from any publishers for you.  
			With noextra cost.
Contact us for more details.

FAQ


Delivery Time
User License
Payment Options
Compare Multiple Reports
















About
Contact
User Guide
Policies
Site Map



© Copyright 1997-2017, Global Information, Inc. All rights reserved.




 







Acucela Inc. - Product Pipeline Review - 2015
















About Us
Solutions 

Resources

eBooks/White Papers
Slideshares
Videos
Blog


Contact Us
Register
Log in
My Account
Logout














Browse Research










My Cart
















Menu  
                                    





 Close   X














Browse








About Us
Solutions
Resources
Contact Us

Log Out
Register
Log in











Life Sciences»Pharmaceuticals»Pharmaceuticals Company Reports 



Acucela Inc. - Product Pipeline Review - 2015


Lowest Prices Guaranteed
Length
Publisher
Published Date
SKU


from $1,500
27 Pages


Global Markets Direct




March, 2015
                                

GMD5530401





Lowest Prices Guaranteed


Price
from $1,500


Length
27 Pages


Publisher

Global Markets Direct



Published Date

March, 2015

                            


SKU
GMD5530401



Table of Contents




Close Window
Table of Contents




Acucela Inc. - Product Pipeline Review - 2015


Printer format



Global Markets Direct

Acucela Inc. Snapshot Acucela Inc. Overview Key Information Key Facts Acucela Inc. - Research and Development Overview Key Therapeutic Areas Acucela Inc. - Pipeline Review Pipeline Products by Stage of Development Pipeline Products - Monotherapy Pipeline Products - Partnered Products Partnered Products/Combination Treatment Modalities Acucela Inc. - Pipeline Products Glance Acucela Inc. - Late Stage Pipeline Products Phase III Products/Combination Treatment Modalities Acucela Inc. - Early Stage Pipeline Products Preclinical Products/Combination Treatment Modalities Acucela Inc. - Drug Profiles emixustat hydrochloride Product Description Mechanism of Action R&D Progress Small Molecule for Retinitis Pigmentosa Product Description Mechanism of Action R&D Progress Small Molecule for Retinopathy of Prematurity Product Description Mechanism of Action R&D Progress Small Molecule for Stargardt Disease Product Description Mechanism of Action R&D Progress Acucela Inc. - Pipeline Analysis Acucela Inc. - Pipeline Products by Target Acucela Inc. - Pipeline Products by Route of Administration Acucela Inc. - Pipeline Products by Molecule Type Acucela Inc. - Pipeline Products by Mechanism of Action Acucela Inc. - Recent Pipeline Updates Acucela Inc. - Dormant Projects Acucela Inc. - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer List of TablesAcucela Inc., Key Information Acucela Inc., Key Facts Acucela Inc. - Pipeline by Indication, 2015 Acucela Inc. - Pipeline by Stage of Development, 2015 Acucela Inc. - Monotherapy Products in Pipeline, 2015 Acucela Inc. - Partnered Products in Pipeline, 2015 Acucela Inc. - Partnered Products/ Combination Treatment Modalities, 2015 Acucela Inc. - Phase III, 2015 Acucela Inc. - Preclinical, 2015 Acucela Inc. - Pipeline by Target, 2015 Acucela Inc. - Pipeline by Route of Administration, 2015 Acucela Inc. - Pipeline by Molecule Type, 2015 Acucela Inc. - Pipeline Products by Mechanism of Action, 2015 Acucela Inc. - Recent Pipeline Updates, 2015 Acucela Inc. - Dormant Developmental Projects,2015 Acucela Inc., Other Locations List of FiguresAcucela Inc. - Pipeline by Top 10 Indication, 2015 Acucela Inc. - Pipeline by Stage of Development, 2015 Acucela Inc. - Monotherapy Products in Pipeline, 2015 Acucela Inc. - Partnered Products in Pipeline, 2015 Acucela Inc. - Pipeline by Top 10 Target, 2015 Acucela Inc. - Pipeline by Top 10 Route of Administration, 2015 Acucela Inc. - Pipeline by Top 10 Molecule Type, 2015 Acucela Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 




Description




Close Window
Description




Acucela Inc. - Product Pipeline Review - 2015


Printer format



Global Markets Direct


Acucela Inc. - Product Pipeline Review - 2015SummaryGlobal Markets Direct’s, ‘Acucela Inc. - Product Pipeline Review - 2015’, provides an overview of the Acucela Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.ScopeThe report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiariesThe report reviews current pipeline of Acucela Inc.’s human therapeutic division and enlists all their major and minor projectsThe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones Special feature on out-licensed and partnered product portfolioThe report summarizes all the dormant and discontinued pipeline projectsLatest company statement Latest news and deals relating to the Acucela Inc.’s pipeline productsReasons to buyEvaluate Acucela Inc.’s strategic position with total access to detailed information on its product pipelineAssess the growth potential of Acucela Inc. in its therapy areas of focusIdentify new drug targets and therapeutic classes in the Acucela Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areasExploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gapsDevelop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunitiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantagePlan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc.Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeExplore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areasAvoid Intellectual Property Rights related issues





Search inside this report




Close Window
Search inside this report
















Online Download
$1,500


Purchase






Site License
$3,000


Purchase






Global Site License
$4,500


Purchase










 



Research assistance



US: 800.298.5699
Int'l: +1.240.747.3093
















      Download our eBook: How to Succeed Using Market Research
    

      Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
    

        Download eBook
    



Share this report









Other tasks

Printer format
Order by fax
Currency converter




































 







Pharmaceuticals Market Research Reports & Pharmaceuticals Industry Analysis | MarketResearch.com



















About Us
Solutions 

Resources

eBooks/White Papers
Slideshares
Videos
Blog


Contact Us
Register
Log in
My Account
Logout














Browse Research










My Cart
















Menu  
                                    





 Close   X














Browse








About Us
Solutions
Resources
Contact Us

Log Out
Register
Log in














Market Research
»

Life Sciences

Pharmaceuticals Market Research Reports & Industry Analysis


The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.  The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction. 
...Show More
...Show Less






Filter your search

Filter your search




Anesthesia (60)
Antibiotic (286)
Biopharmaceuticals (231)
Biopharmacology (14)
Clinical Nutrition (90)
Clinical Trial (2321)
Country Overviews (448)
Dietary Supplements (1165)
Diseases & Conditions (6715)
Drug Delivery (221)
Drug Discovery (7820)
General Pharmaceuticals (295)
Generics Drugs (186)
Manufacturing, Packaging & Detailing (4068)
Over-the-Counter Drugs (1623)
Pharmaceuticals Company Reports (4912)
Pharmacy & Distribution (132)
Prescription Drugs (2402)
Pricing (43)
Regulation & Policy (234)
Research & Development (1398)
Technology (20)
Therapeutic Area (8424)
Vaccines (628)




Global  (8310)
Europe  (3964)
Asia  (3233)
North America  (2372)
South America  (360)
Africa  (311)
Oceania  (240)
Middle East  (211)
Caribbean  (34)
Central America  (32)




Research Assistance
US: 800.298.5699 
Int'l: +1.240.747.3093






Join Alert Me Now!
Receive bi-weekly email alerts on new research
Sign Up

Find out more on our blog



Pharmaceuticals Industry Research & Market Reports

Sort by:

Title A-Z
Title Z-A
Price Low-to-High
Price High-to-Low
Date
Date (Older First)

Refine your search




Close Window
Refine your search








Title:







Publisher:







Keyword:







Price(USD):





 To 







Date:



Any Date
Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years





Region:



All Regions

                                                            Africa
                                                        

                                                               Algeria
                                                        

                                                               Angola
                                                        

                                                               Benin
                                                        

                                                               Botswana
                                                        

                                                               Burkina Faso
                                                        

                                                               Burundi
                                                        

                                                               Cameroon
                                                        

                                                               Cape Verde
                                                        

                                                               Central African Republic
                                                        

                                                               Chad
                                                        

                                                               Comoros
                                                        

                                                               The Congo
                                                        

                                                               The Congo
                                                        

                                                               Cote d'Ivoire
                                                        

                                                               Djibouti
                                                        

                                                               Egypt
                                                        

                                                               Equatorial Guinea
                                                        

                                                               Eritrea
                                                        

                                                               Ethiopia
                                                        

                                                               Gabon
                                                        

                                                               The Gambia
                                                        

                                                               Ghana
                                                        

                                                               Guinea
                                                        

                                                               Guinea-Bissau
                                                        

                                                               Kenya
                                                        

                                                               Lesotho
                                                        

                                                               Liberia
                                                        

                                                               Libya
                                                        

                                                               Madagascar
                                                        

                                                               Malawi
                                                        

                                                               Mali
                                                        

                                                               Mauritania
                                                        

                                                               Mauritius
                                                        

                                                               Mayotte
                                                        

                                                               Morocco
                                                        

                                                               Mozambique
                                                        

                                                               Namibia
                                                        

                                                               Niger
                                                        

                                                               Nigeria
                                                        

                                                               Reunion
                                                        

                                                               Rwanda
                                                        

                                                               Sao Tome and Principe
                                                        

                                                               Senegal
                                                        

                                                               Seychelles
                                                        

                                                               Sierra Leone
                                                        

                                                               Somalia
                                                        

                                                               South Africa
                                                        

                                                               South Sudan
                                                        

                                                               Sudan
                                                        

                                                               Swaziland
                                                        

                                                               Tanzania
                                                        

                                                               Togo
                                                        

                                                               Tunisia
                                                        

                                                               Uganda
                                                        

                                                               Western Sahara
                                                        

                                                               Zambia
                                                        

                                                               Zimbabwe
                                                        

                                                            Asia
                                                        

                                                               Afghanistan
                                                        

                                                               Armenia
                                                        

                                                               Azerbaijan
                                                        

                                                               Bangladesh
                                                        

                                                               Bhutan
                                                        

                                                               Brunei
                                                        

                                                               Cambodia
                                                        

                                                               China
                                                        

                                                               Cocos (Keeling) Islands
                                                        

                                                               East Timor
                                                        

                                                               Georgia
                                                        

                                                               Hong Kong
                                                        

                                                               India
                                                        

                                                               Indonesia
                                                        

                                                               Japan
                                                        

                                                               Kazakhstan
                                                        

                                                               Kyrgyzstan
                                                        

                                                               Laos
                                                        

                                                               Macau
                                                        

                                                               Malaysia
                                                        

                                                               Maldives
                                                        

                                                               Mongolia
                                                        

                                                               Myanmar
                                                        

                                                               Nepal
                                                        

                                                               North Korea
                                                        

                                                               Pakistan
                                                        

                                                               Papua New Guinea
                                                        

                                                               Philippines
                                                        

                                                               Russia
                                                        

                                                               Singapore
                                                        

                                                               South Korea
                                                        

                                                               Sri Lanka
                                                        

                                                               Taiwan
                                                        

                                                               Tajikistan
                                                        

                                                               Thailand
                                                        

                                                               Turkey
                                                        

                                                               Turkmenistan
                                                        

                                                               Uzbekistan
                                                        

                                                               Vietnam
                                                        

                                                            Caribbean
                                                        

                                                               Anguilla
                                                        

                                                               Antigua and Barbuda
                                                        

                                                               Aruba
                                                        

                                                               The Bahamas
                                                        

                                                               Barbados
                                                        

                                                               British Virgin Islands
                                                        

                                                               Cayman Islands
                                                        

                                                               Cuba
                                                        

                                                               Curacao
                                                        

                                                               Dominica
                                                        

                                                               Dominican Republic
                                                        

                                                               Grenada
                                                        

                                                               Guadeloupe
                                                        

                                                               Haiti
                                                        

                                                               Jamaica
                                                        

                                                               Martinique
                                                        

                                                               Montserrat
                                                        

                                                               Netherlands Antilles
                                                        

                                                               Puerto Rico
                                                        

                                                               Saint Kitts and Nevis
                                                        

                                                               Saint Lucia
                                                        

                                                               Saint Vincent and the Grenadines
                                                        

                                                               Sint Maarten/ Saint Maarten
                                                        

                                                               Trinidad and Tobago
                                                        

                                                               Turks and Caicos Islands
                                                        

                                                               Virgin Islands
                                                        

                                                            Central America
                                                        

                                                               Belize
                                                        

                                                               Costa Rica
                                                        

                                                               El Salvador
                                                        

                                                               Guatemala
                                                        

                                                               Honduras
                                                        

                                                               Nicaragua
                                                        

                                                               Panama
                                                        

                                                            Europe
                                                        

                                                               Albania
                                                        

                                                               Andorra
                                                        

                                                               Austria
                                                        

                                                               Belarus
                                                        

                                                               Belgium
                                                        

                                                               Bosnia and Herzegovina
                                                        

                                                               Bulgaria
                                                        

                                                               Croatia
                                                        

                                                               Czech Republic
                                                        

                                                               Denmark
                                                        

                                                               Estonia
                                                        

                                                               Faroe Islands
                                                        

                                                               Finland
                                                        

                                                               France
                                                        

                                                               Germany
                                                        

                                                               Gibraltar
                                                        

                                                               Greece
                                                        

                                                               Guernsey
                                                        

                                                               Hungary
                                                        

                                                               Iceland
                                                        

                                                               Ireland
                                                        

                                                               Isle of Man
                                                        

                                                               Italy
                                                        

                                                               Jersey
                                                        

                                                               Kosovo
                                                        

                                                               Latvia
                                                        

                                                               Liechtenstein
                                                        

                                                               Lithuania
                                                        

                                                               Luxembourg
                                                        

                                                               Macedonia
                                                        

                                                               Malta
                                                        

                                                               Moldova
                                                        

                                                               Monaco
                                                        

                                                               Netherlands
                                                        

                                                               Norway
                                                        

                                                               Poland
                                                        

                                                               Portugal
                                                        

                                                               Romania
                                                        

                                                               San Marino
                                                        

                                                               Scotland
                                                        

                                                               Serbia and Montenegro
                                                        

                                                               Slovakia
                                                        

                                                               Slovenia
                                                        

                                                               Spain
                                                        

                                                               Sweden
                                                        

                                                               Switzerland
                                                        

                                                               Ukraine
                                                        

                                                               United Kingdom
                                                        

                                                            Global
                                                        

                                                            Middle East
                                                        

                                                               Bahrain
                                                        

                                                               Cyprus
                                                        

                                                               Gaza Strip
                                                        

                                                               Iran
                                                        

                                                               Iraq
                                                        

                                                               Israel
                                                        

                                                               Jordan
                                                        

                                                               Kuwait
                                                        

                                                               Lebanon
                                                        

                                                               Oman
                                                        

                                                               Palestinian Territories
                                                        

                                                               Qatar
                                                        

                                                               Saudi Arabia
                                                        

                                                               Syria
                                                        

                                                               United Arab Emirates
                                                        

                                                               Yemen
                                                        

                                                            North America
                                                        

                                                               Bermuda
                                                        

                                                               Canada
                                                        

                                                               Greenland
                                                        

                                                               Mexico
                                                        

                                                               United States
                                                        

                                                            Oceania
                                                        

                                                               American Samoa
                                                        

                                                               Australia
                                                        

                                                               Cook Islands
                                                        

                                                               Fiji
                                                        

                                                               French Polynesia
                                                        

                                                               Guam
                                                        

                                                               Kiribati
                                                        

                                                               Marshall Islands
                                                        

                                                               Micronesia, Federated States of
                                                        

                                                               Nauru
                                                        

                                                               New Caledonia
                                                        

                                                               New Zealand
                                                        

                                                               Niue
                                                        

                                                               Norfolk Island
                                                        

                                                               Northern Mariana Islands
                                                        

                                                               Palau
                                                        

                                                               Samoa
                                                        

                                                               Solomon Islands
                                                        

                                                               Tonga
                                                        

                                                               Tuvalu
                                                        

                                                               Vanuatu
                                                        

                                                            South America
                                                        

                                                               Argentina
                                                        

                                                               Bolivia
                                                        

                                                               Brazil
                                                        

                                                               Chile
                                                        

                                                               Colombia
                                                        

                                                               Ecuador
                                                        

                                                               Falkland Islands
                                                        

                                                               French Guiana
                                                        

                                                               Guyana
                                                        

                                                               Paraguay
                                                        

                                                               Peru
                                                        

                                                               Suriname
                                                        

                                                               Uruguay
                                                        

                                                               Venezuela
                                                        





 Search 











Global Cancer Diagnostics Market Overview 2021: Test Volume and Sales Forecasts by Country, Laboratory Universe
Jul 26, 2017  | USD 2,450
...etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables Please note: The ... Read More


Europe Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures - Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
Jul 26, 2017  | USD 6,900
...analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts ... Read More


Tumor Markers Testing Instrumentation Review: Cancer Diagnostic Analyzers and Strategic Profiles of Leading Suppliers
Jul 26, 2017  | USD 3,850
...testing. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&amp;D, collaborative arrangements and business strategies. Contains ... Read More


Cancer Diagnostic Instrumentation Review: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers
Jul 26, 2017  | USD 3,850
...testing. The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&amp;D, collaborative arrangements and business strategies. ... Read More


Global Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures - Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
Jul 26, 2017  | USD 9,500
...analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test ... Read More


Europe Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 1,250
...is estimated to increase from $434.7 million in 2016 and reach $738.73 million by 2025. MARKET INSIGHTS The market has plenty of growth opportunities owing to the unmet needs of CIC drugs in certain countries. ... Read More


Global Biopreservation Market 2017-2021
Jul 19, 2017  | USD 3,500
...extended period. Earlier, in the field of tissue engineering, cell and tissue transplantation, and genetic engineering, and preserving of engineered cells and tissues with functional viability in an external environment is a major challenge. Technavio’s ... Read More


Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 2,500
...propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is the major type of drug popular in this market. MARKT INSIGHT The ... Read More


Georgia Pharmaceuticals and Healthcare Report Q3 2017
Jul 19, 2017  | USD 1,345
...entice drugmakers to invest in manufacturing facilities the country because of the attractivebusiness environment. Domestic challenges, including the lack of pricing regulation, will pose uniquechallenges for drugmakers exporting into the market. Headline Expenditure Projections Pharmaceuticals: ... Read More


Global Veterinary Clostridium Vaccine Market 2017-2021
Jul 19, 2017  | USD 3,500
...of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals against all the Clostridia diseases. Various types of vaccines are ... Read More


Asia-pacific Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 1,250
...by the market is expected to rise from $303.4 million in 2016 and reach $ 502.4 million by 2025. MARKET INSIGHTS The Asian CIC drug market can be segmented by the type of drug and ... Read More


North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
Jul 19, 2017  | USD 1,250
...rise from $818 million in 2016 to $1527.50 million by 2025. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing increasing elderly population are some of ... Read More


Mitogen Activated Protein Kinase 8 (c Jun N Terminal Kinase 1 or JNK 46 or Stress Activated Protein Kinase JNK1 or Stress Activated Protein Kinase 1c or MAPK8 or EC 2.7.11.24) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...H2 2017 Summary Mitogen Activated Protein Kinase 8 (c Jun N Terminal Kinase 1 or JNK 46 or Stress Activated Protein Kinase JNK1 or Stress Activated Protein Kinase 1c or MAPK8 or EC 2.7.11.24) pipeline ... Read More


Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...64 or IRAK4 or EC 2.7.11.1) - Interleukin-1 receptor-associated kinase 4 (IRAK-4) is a protein kinase involved in signaling innate immune responses from Toll-like receptors. Mutations in IRAK-4 result in IRAK4 deficiency and recurrent invasive ... Read More


Botulism - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...is a rare but serious illness. The cause is a toxin (poison) made by a bacterium called Clostridium botulinum. It occurs naturally in soil. Food borne botulism comes from eating foods contaminated with the toxin. ... Read More


Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...to the recently published report 'Protein Glutamine Gamma Glutamyltransferase 2 - Pipeline Review, H2 2017'; Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or ... Read More


Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...Summary Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Rho-Associated Protein Kinase 1 ... Read More


Male Hypogonadism - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...pipeline landscape. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteoporosis). Risk factors for hypogonadism ... Read More


Hypoglycemia - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...is a condition characterized by an abnormally low level of blood sugar (glucose). Symptoms of hypoglycemia include tachycardia, anxiety, shaking, and irritability, feelings of hunger, weakness, tiredness, dizziness, headache, confusion, and trouble concentrating. Risk factors ... Read More


Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 7,000
...H2 2017'; Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and ... Read More


Cholera - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...is an acute infectious disease caused by a bacterium, Vibrio cholera, which results in a painless, watery diarrhea in humans. Symptoms of cholera can begin as soon as a few hours or as long as ... Read More


Phenylketonuria (PKU) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...pipeline landscape. Phenylketonuria (also called PKU), is a rare inherited disorder that causes an amino acid called phenylalanine to build up in body. Symptoms include intellectual disability, psychiatric disorders, hyperactivity, skin rashes, poor bone strength ... Read More


China Human Vaccine Industry Report, 2017-2021
Jul 18, 2017  | USD 2,800
...Mar 2016 in Shandong, the country’s lot release volume of human vaccines came to 553.6 million doses through the year 2016, down 3.8% over the previous year. The lot release volume of ten vaccines (Hepatitis ... Read More


Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...(Scleroderma) (Immunology) pipeline landscape. Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pains, joint pain and swelling, ulcers occurring on fingertips, ... Read More


Amyloidosis - Pipeline Review, H2 2017
Jul 18, 2017  | USD 4,000
...accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning of the organ eventually leading to organ failure. Predisposing factors are misfolding ... Read More



< prev 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
  next > 




Start New Browse


Consumer Goods
Food & Beverage
Heavy Industry
Life Sciences
Marketing & Market Research
Public Sector
Service Industries
Technology & Media
 Company Reports
Reports by Country
View all Market Areas
View all Publishers






































	Market Report: Acucela Inc. - Product Pipeline Review - 2015

















































ABOUT US

• PUBLISHERS
• CONTACT US
• CART




Login | Register















All Industries
Business & Finance
-- Business
-- Financial Services
-- Insurance
-- Marketing
Consumer & Food
-- Beverages
-- Consumer Goods
-- Food
-- Retailing
Healthcare
-- Biotechnology
-- Healthcare
-- Medical Devices
-- Pharmaceuticals
Heavy Industry
-- Construction
-- Energy
-- Manufacturing
-- Materials
-- Transportation
Internet & Media
-- E-Business
-- Internet
-- Media
-- Publishing
Public Sector
-- Defense
-- Education
-- Government
Telecom & Computing
-- Computer Technology
-- Fixed Networks
-- Software
-- Wireless
Company/Country Reports
-- Company Reports
-- Country Reports
-- Regional Reports


 
            













                        Processing...




Acucela Inc. - Product Pipeline Review - 2015

     
                        Mar 11, 2015 - Global Markets Direct 
                    
                - 27 pages 
                - USD $1,500 
         





Click here to open the POPUP


                        You've added the following report to your cart:CLOSE








Cart Summary



                                    Total Items: 
                                

                                    SubTotal: 
                                


    









Report Summary


Table of Contents


Companies


Request Details


Related







Global Markets Direct's, 'Acucela Inc. - Product Pipeline Review - 2015', provides an overview of the Acucela Inc.'s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Acucela Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.ScopeThe report provides brief overview of Acucela Inc. including business description, key information and facts, and its locations and subsidiariesThe report reviews current pipeline of Acucela Inc.'s human therapeutic division and enlists all their major and minor projectsThe report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestonesSpecial feature on out-licensed and partnered product portfolioThe report summarizes all the dormant and discontinued pipeline projectsLatest company statementLatest news and deals relating to the Acucela Inc.'s pipeline productsReasons to buyEvaluate Acucela Inc.'s strategic position with total access to detailed information on its product pipelineAssess the growth potential of Acucela Inc. in its therapy areas of focusIdentify new drug targets and therapeutic classes in the Acucela Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areasExploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gapsDevelop strategic initiatives by understanding the focus areas of Acucela Inc. and exploit collaboration and partnership opportunitiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantagePlan mergers and acquisitions effectively by identifying the most promising pipeline of Acucela Inc.Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeExplore the dormant and discontinued projects of Acucela Inc. and identify potential opportunities in those areasAvoid Intellectual Property Rights related issues
Table of ContentsTable of ContentsList of TablesList of FiguresAcucela Inc. SnapshotAcucela Inc. OverviewKey InformationKey FactsAcucela Inc. - Research and Development OverviewKey Therapeutic AreasAcucela Inc. - Pipeline ReviewPipeline Products by Stage of DevelopmentPipeline Products - MonotherapyPipeline Products - Partnered ProductsPartnered Products/Combination Treatment ModalitiesAcucela Inc. - Pipeline Products GlanceAcucela Inc. - Late Stage Pipeline ProductsPhase III Products/Combination Treatment ModalitiesAcucela Inc. - Early Stage Pipeline ProductsPreclinical Products/Combination Treatment ModalitiesAcucela Inc. - Drug Profilesemixustat hydrochlorideProduct DescriptionMechanism of ActionR&D ProgressSmall Molecule for Retinitis PigmentosaProduct DescriptionMechanism of ActionR&D ProgressSmall Molecule for Retinopathy of PrematurityProduct DescriptionMechanism of ActionR&D ProgressSmall Molecule for Stargardt DiseaseProduct DescriptionMechanism of ActionR&D ProgressAcucela Inc. - Pipeline AnalysisAcucela Inc. - Pipeline Products by TargetAcucela Inc. - Pipeline Products by Route of AdministrationAcucela Inc. - Pipeline Products by Molecule TypeAcucela Inc. - Pipeline Products by Mechanism of ActionAcucela Inc. - Recent Pipeline UpdatesAcucela Inc. - Dormant ProjectsAcucela Inc. - Locations And SubsidiariesHead OfficeOther Locations & SubsidiariesAppendixMethodologyCoverageSecondary ResearchPrimary ResearchExpert Panel ValidationContact UsDisclaimerList of TablesAcucela Inc., Key InformationAcucela Inc., Key FactsAcucela Inc. - Pipeline by Indication,Acucela Inc. - Pipeline by Stage of Development,Acucela Inc. - Monotherapy Products in Pipeline,Acucela Inc. - Partnered Products in Pipeline,Acucela Inc. - Partnered Products/ Combination Treatment Modalities,Acucela Inc. - Phase III,Acucela Inc. - Preclinical,Acucela Inc. - Pipeline by Target,Acucela Inc. - Pipeline by Route of Administration,Acucela Inc. - Pipeline by Molecule Type,Acucela Inc. - Pipeline Products by Mechanism of Action,Acucela Inc. - Recent Pipeline Updates,Acucela Inc. - Dormant Developmental Projects,Acucela Inc., Other LocationsList of FiguresAcucela Inc. - Pipeline by Top 10 Indication,Acucela Inc. - Pipeline by Stage of Development,Acucela Inc. - Monotherapy Products in Pipeline,Acucela Inc. - Partnered Products in Pipeline,Acucela Inc. - Pipeline by Top 10 Target,Acucela Inc. - Pipeline by Top 10 Route of Administration,Acucela Inc. - Pipeline by Top 10 Molecule Type,Acucela Inc. - Pipeline Products by Top 10 Mechanism of Action,
Companies Mentioned in this ReportAcucela Inc.
This report does not have a press release associated with it









Order Today!

FORMAT: PDF 
$1,500  USD
LICENSE: Single User 
DELIVERY: By Email - 1 Business Day


























The Fast Market Research Advantage

Only the Best
            All of our research is sourced from the most trusted and established global analysts and consultancies
Client Focused
            From start-ups to multinationals, we focus on providing the right research to our diverse client base
Shop Securely
            Our US-based customer service team and eCommerce systems adhere to the highest data security standards
Industry-leading Customer Support
            Individualized assistance from our expert staff is never more than an email or phone call away




BEST PRICE GUARANTEE
We are committed to providing the best research at the lowest cost.  We will match any published price for the same report, guaranteed!



EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process
using any major credit card, check or wire/bank transfer.Need multi-user or enterprise license pricing?  Contact us for a custom quote!
                  




About the Publisher
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Publisher Details







Privacy Policy | Terms of Use | FLASHALERTS


Copyright &copy 2017 Fast Market Research, Inc.



















Acucela Inc - Seattle, WA - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



WA



Seattle



Commercial Physical Research



Biotechnical Research, Commercial



                            Acucela Inc
                                    



 





















A 


Acucela Inc
CLAIM THIS BUSINESS



454 N 34TH ST SEATTLE, WA 98103
Get Directions



(206) 812-1530
www.acucela.com





Business Info



 Founded 2010
 Incorporated 
 Annual Revenue $170,000.00
 Employee Count 3
 Industries Biotechnical Research, Commercial
 Contacts Ryo Kubota







Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


Acucela Inc is located at 454 N 34th St in Seattle and has been in the business of Biotechnical Research, Commercial since 2010. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







A

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com












Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.

















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












Womens Clothing - Designer Brands & Fashion - Macy's



















































  







       Sign In   Stores  Book An Appointment Find a Store Find an Event   Stores Customer Service                                               my bag (0)       WOMEN     Women's Clothing   Activewear   Basic Clothing   Blazers   Capris   Coats   Dresses   Jackets   Jeans   Jumpsuits & Rompers   Leggings   Lingerie & Shapewear   Maternity   Pajamas & Robes   Pants   Shorts   Skirts   Suits & Suit Separates   Sweaters   Swimwear   Tights, Socks, & Hosiery   Tops   Wear to Work       Plus Sizes   Dresses   Pants & Capris   Swimwear   Tops   Trendy Plus Size   All Plus Sizes     Petites   Cardigans   Dresses   Jeans   Pants & Capris   Tops   All Petites     New & Now   Avec Les Filles   Bare Shoulder   Graphic Tees & Sweatshirts   New Arrivals   Soft Pant   Trend Shop       Women's Brands   Adrianna Papell   Alfani   Calvin Klein   Charter Club   INC International Concepts   Lauren Ralph Lauren   MICHAEL Michael Kors   Nike   Style & Co   The Fur Vault   The North Face   Tommy Hilfiger   Under Armour   Vince Camuto   See All Brands     Featured Shops   Cashmere Shop   Dress Edit   Must Haves   Petite Fit Guide   Plus Must Haves & Fit Guide   Sports Fan Shop By Lids   Swim Finder   The Wedding Shop       Contemporary Brands   Bar III   Free People   Levi's   Lucky Brand   RACHEL Rachel Roy   All Contemporary Clothing     Designer Brands   Eileen Fisher   Polo Ralph Lauren   All Designer Clothing     Shoes, Handbags, & More   Beauty   Handbags   Belts, Hats & Scarves   Jewelry & Watches   Shoes   Sunglasses   Tech Shop     Pop-Up Sale   40-70% off Clearance      MEN  HOME  BED & BATH  SHOES  HANDBAGS  BEAUTY  KIDS  JUNIORS  JEWELRY  WATCHES  ACTIVE  BRANDS      Wedding Registry Gift Cards Deals & Promotions Lists                DAL header-xapi 07/25/2017 09:06:22 EDT 17L  Wed Jun 14 18:39:25 UTC 2017 0.11.1 




Popular Searches
Coach Handbags Lauren Ralph Lauren Women's Michael Kors Michael Kors Handbags Michael Kors Shoes Polo Ralph Lauren Men's Tommy Hilfiger Women's Women's Dresses Women's Sandals Women's Tops



Womens ClothingExperience the excitement of shopping! With a dazzling selection of women’s apparel, you’re sure to score on stylish pieces for comfy casual looks, elegant formal ensembles and everything in between. Stay on trend with the latest looks and find some new favorites—or simply restock on basics that every woman needs.Looking for tops? Casual tees and shirts are perfect for relaxing in on your days off, while blouses and tunics work great for the office or other dressier occasions. Going for more structured styling? Check out the selection of suits and suit separates for a head-to-toe sharp look, or add a touch of polish to any outfit with a blazer. Before the first of winter chills, stock up on sweaters and cardigans in cozy cashmere, wool, cotton and more. Then, layer on a puffer or pea coat for unbeatable warmth; stick with a lighter jacket for milder weather.Searching for bottoms? Dress down with denim and choose from the collection of women’s jeans available in a wide variety of figure-flattering fits and washes. Add shorts and skirts to your casual rotation too. Keep it simple in pants or switch it up with rompers and jumpsuits. Need something fancier for a night out? Dress up in a glamorous evening gowns and chic cocktail dresses for formal occasions. Get a good workout in activewear from your favorite sports brands. Discover gear specially designed for specific sports and score on all types of exercise essentials. But when it’s time to rest, snuggle up in the comfiest of pajamas and robes. Also look for luxurious lingerie along with basic bras and underwear for everyday wear. And before you hit the waves, prep with the perfect poolside look in the hottest styles of swimwear.Shopping for clothing has never been easier—from timeless classics to up-to-the-minute trends, Macy’s has it all. And with a wide range of sizes including petite and plus, you’re sure to get the perfect fit. Don’t forget to check out prom dresses and the juniors collection to stay on the pulse of contemporary fashion! Looking for huge savings? Shop our Black Friday, Cyber Monday and Holiday Gift Guide!












To ensure you're getting the best shopping experience, please enable JavaScript in your browser preferences.








Women



pop-up sale


40-70% off clearance


women's clothing


Activewear


Basic Clothing


Blazers


Capris


Coats


Dresses


Jackets


Jeans


Jumpsuits & Rompers


Leggings


Lingerie & Shapewear


Maternity


Pajamas & Robes


Pants


Shorts


Skirts


Suits & Suit Separates


Sweaters


Swimwear


Tights, Socks & Hosiery


Tops


Vests


Wear to Work




plus sizes


Dresses


Pants & Capris


Swimwear


Tops


Trendy Plus Sizes


All Plus Sizes




petite plus size


All Petite Plus Size




petites


Cardigans


Dresses


Jeans


Pants & Capris


Tops


All Petites




maternity


A Pea in the Pod


Motherhood Maternity


All Maternity




contemporary & designer


Contemporary Clothing


Designer Clothing





women's brands



Alfani



Alfani



Calvin Klein



Calvin Klein



Charter Club



Charter Club



Free People



Free People



INC International Concepts



INC International Concepts



Lauren Ralph Lauren



Lauren Ralph Lauren



MICHAEL Michael Kors



MICHAEL Michael Kors



Style & Co



Style & Co



The North Face



The North Face



Tommy Hilfiger



Tommy Hilfiger




Vince Camuto




32 Degrees




American Living




Anne Klein




Bar III




BCBGMAXAZRIA




Catherine Malandrino




DKNY




CR by Cynthia Rowley




Eileen Fisher




Ideology




Ivanka Trump




JM Collection




Jones New York




Karen Kane




Karen Scott




Lee Platinum




Nautica




Nike




NY Collection




NYDJ




Polo Ralph Lauren




RACHEL Rachel Roy




Tahari ASL




Thalia Sodi




Under Armour




Adidas




Adrianna Papell




Alfred Dunner




Avec Les Filles




B Michael




CeCe




ECI




Fame and Partners




G.H. Bass & Co.




Levi's




Yigal Azrouel



See All Brands




featured shops


#macyslove Photo Gallery


Cashmere Shop


Denim Destination


Dress Edit


Must Haves


New Arrivals


Sports Fan Shop By Lids


The Fur Vault


The Wedding Shop




coming soon


Anna Sui x INC


Kobi Halperin




shoes & accessories


Beauty


Handbags & Accessories


Hats, Gloves & Scarves


Shoes


Sunglasses


LensCrafters




sale & clearance






 







10

























 
























Shop our Ultimate Pop-Up Sale 










25-40% Off Contemporary & Designer Brands







25-40% Off Select Dresses







40-75% Off Select Tops







25% Off Select Activewear






















Dresses














Tops























Swim














Pants & Capris























Skirts














Shorts























Wear To Work














Jeans























































































 





































 













Overview







Read all reviews








or call 1 800 BUY MACY (289 6229)


See Full Product Details



Qty:



















118
Women
QUICKVIEW

 


































 







  MCOM footer-xapi 07/25/2017 08:35:40 EDT 17L  Wed Jun 14 18:39:25 UTC 2017 0.11.1 
















































DAL
catalog -
catSplash
Page Layout - Canvas
navapp_replica_m1
ma209mlvnav003
07/25/2017 09:24:28 EDT
17L
 Sat Jul 8 01:05:37 UTC 2017
2.81.39





Plus Size Clothing for Women - Macy's



















































  







       Sign In   Stores  Book An Appointment Find a Store Find an Event   Stores Customer Service                                               my bag (0)       WOMEN     Women's Clothing   Activewear   Basic Clothing   Blazers   Capris   Coats   Dresses   Jackets   Jeans   Jumpsuits & Rompers   Leggings   Lingerie & Shapewear   Maternity   Pajamas & Robes   Pants   Shorts   Skirts   Suits & Suit Separates   Sweaters   Swimwear   Tights, Socks, & Hosiery   Tops   Wear to Work       Plus Sizes   Dresses   Pants & Capris   Swimwear   Tops   Trendy Plus Size   All Plus Sizes     Petites   Cardigans   Dresses   Jeans   Pants & Capris   Tops   All Petites     New & Now   Avec Les Filles   Bare Shoulder   Graphic Tees & Sweatshirts   New Arrivals   Soft Pant   Trend Shop       Women's Brands   Adrianna Papell   Alfani   Calvin Klein   Charter Club   INC International Concepts   Lauren Ralph Lauren   MICHAEL Michael Kors   Nike   Style & Co   The Fur Vault   The North Face   Tommy Hilfiger   Under Armour   Vince Camuto   See All Brands     Featured Shops   Cashmere Shop   Dress Edit   Must Haves   Petite Fit Guide   Plus Must Haves & Fit Guide   Sports Fan Shop By Lids   Swim Finder   The Wedding Shop       Contemporary Brands   Bar III   Free People   Levi's   Lucky Brand   RACHEL Rachel Roy   All Contemporary Clothing     Designer Brands   Eileen Fisher   Polo Ralph Lauren   All Designer Clothing     Shoes, Handbags, & More   Beauty   Handbags   Belts, Hats & Scarves   Jewelry & Watches   Shoes   Sunglasses   Tech Shop     Pop-Up Sale   40-70% off Clearance      MEN  HOME  BED & BATH  SHOES  HANDBAGS  BEAUTY  KIDS  JUNIORS  JEWELRY  WATCHES  ACTIVE  BRANDS      Wedding Registry Gift Cards Deals & Promotions Lists                DAL header-xapi 07/25/2017 08:51:10 EDT 17L  Wed Jun 14 18:39:25 UTC 2017 0.11.1 




Popular Searches
Bathing Suits Calvin Klein Calvin Klein Dresses Lauren Ralph Lauren Women's Michael Kors Nike Women's Tommy Hilfiger Women's Tops - Plus Size Women's Dresses Women's Tops



Plus Size ClothingLooking for an amazing selection of plus size clothes for women? There are so many styles, colors and brands waiting for you to discover. Shop stylish options for all occasions and find many pieces available in fun, vibrant colors such as sizzling confident red, warm blush pink, and soft, feminine purple.
For casual day-to-day outfits, find cute and comfortable tops along with figure flattering plus size jeans. A pair of slim rocker boot-cut blue jeans from Seven7 pairs matches well with a blouse, tee-shirt, sweater or jacket. For plus size clothing for women with dramatic contrast and just as much comfort, slip into some straight leg black wash jeans from Not Your Daughter's Jeans. And go feminine chick with a long sleeve shawl in luxurious cashmere. Get great tops for any season from tank tops to sweaters.
Polish your work wardrobe with sharp and sophisticated plus size pant suits and skirt suits. Mix and match suit separates from Anne Klein blazers with bottoms of our choice. Look for slimming pinstripe trousers or office appropriate pencil skirts in extended sizes. Tahari offers lovely textured jackets and Kasper Suits features beautiful prints.
Find a wonderful selection of dressy plus size clothes for women. Start a special evening out by slipping into dazzling formalwear or add some eye catching contrast with a one-shouldered a-line dress from International Concepts. Ruby Rox carries plus size dresses for attending an evening event or a wedding. For more casual occasions and day-to-day wear, look for dresses that can be worn to work or to a dinner date.
From suit jackets to halter tops and evening gowns to jeans, you'll find fashionable plus size clothing for women you're looking for at macys.com. Shop at Macy’s for the latest trends in regular and extended sizes.












To ensure you're getting the best shopping experience, please enable JavaScript in your browser preferences.








Plus Sizes



pop-up sale


40-70% off clearance


plus size clothing


Activewear


Coats


Dresses


Graphic Tees


Jackets & Blazers


Jeans


Jumpsuits & Rompers


Leggings


Lingerie & Shapewear


Maternity


Pajamas & Robes


Pants & Capris


Shorts


Skirts


Suits & Suit Separates


Sweaters


Swimwear


Tops


Trendy Plus Sizes


Vests


Wear to Work




petite plus size


All Petite Plus Size





plus size brands



Alfani



Alfani



Anne Klein



Anne Klein



Calvin Klein



Calvin Klein



Charter Club



Charter Club



City Chic



City Chic



INC International Concepts



INC International Concepts



Lauren Ralph Lauren



Lauren Ralph Lauren



MICHAEL Michael Kors



MICHAEL Michael Kors



Style & Co



Style & Co



Tommy Hilfiger



Tommy Hilfiger




Rachel Rachel Roy Curvy Collection




American Rag




Jessica Simpson




JM Collection




Karen Scott




Melissa McCarthy Seven7




Silver Jeans




Celebrity Pink Plus




Jones New York




Levi's




Lucky Brand Jeans




Tahari ASL




Ideology




Material Girl




SLINK Jeans




mblm by Tess Holliday



See All Brands




featured shops


#macyslove Photo Gallery


Back To School


Denim Destination


Dress Edit


How to Wear it


Must Haves & Fit Guide


The Wedding Shop




shoes & accessories


Handbags & Accessories


Hats, Scarves & Wraps


Hosiery


Shoes


Sunglasses




plus size sale & clearance






 







10

























 
























Shop our Ultimate Pop-Up Sale










40-75% Off Select Tops







40-75% Off Select Shorts & Capris







40-75% Off Select Dresses







25-40% off Trendy Plus & Designer






















Tops














Dresses























Pants & Capris














Cardigans























Swim














Shorts























Jeans














Jackets & Blazers


































































































 





































 













Overview







Read all reviews








or call 1 800 BUY MACY (289 6229)


See Full Product Details



Qty:



















32147
Plus Sizes
QUICKVIEW

 


































 







  MCOM footer-xapi 07/25/2017 08:35:40 EDT 17L  Wed Jun 14 18:39:25 UTC 2017 0.11.1 
















































DAL
catalog -
catSplash
Page Layout - Canvas
navapp_replica_m1
ma209mlvnav003
07/25/2017 09:24:35 EDT
17L
 Sat Jul 8 01:05:37 UTC 2017
2.81.39




#GoYou | Macy's Health & Fitness Guide – Macy's





MACY'SIS YOURCENTERFOR EATING,LIVING &BEING WELLIN THE 21stCENTURY#GOYOUSTRENGTHEN YOUR FORMNOURISH YOUR BODYRESTORE YOUR SOULCHOOSE WHAT MAKES YOU SWEAT:TRAININGWOMENMENRUNNINGWOMENMENOUTDOORSWOMENMENGOLFWOMENMENFINISH LINEOUT AND ABOUT IN THE LATESTWOMENMENKIDSBRANDS WE LOVENOURISHWe all know health is an inside job. It's time to hit the kitchen.SHOP THE ESSENTIALSTOP 10 NOURISH PICKS  
	                                FEATURED CATEGORIESJuicersBlendersWater BottlesCulinary CouncilCookware & ElectricsKitchen GadgetsBRANDS WE LOVETIPS FOR A HEALTHIERNEW YEARWhether you resolved to lose weight or simply want to fuel up for a busy day, check out these tips from the Macy's Culinary Council.CHECK IT OUTRESTORER&R speeds up recovery. Here's how to treat yourself better.SHOP THE ESSENTIALSTOP 10 RESTORE PICKS FEATURED CATEGORIESSunscreens & LotionsMattressesSleep SolutionsAir PurifiersPersonal CareSport SunglassesBRANDS WE LOVE×
	                Your browser does not support the video tag. 
	            













acucela - NetFind Content Results










AOL Search
Skip over navigation


















Search the Web




























Web


Web



Content











Acucela Jobs - 2 Open Positions Left -- Apply Now!



Ad
 ·
Acucela-Jobs.jobsgalore.com/​



2 Open Positions Left -- Apply Now! Acucela Jobs





Receive Daily Job Alerts



Post a Job




About our Job Search



Find Your New Job





Shaklee Product Center | buy-products.myshaklee.com



Ad
 ·
http:/​/​buy-products.myshaklee.com



Your Online Source for Shaklee Products. Shaklee Dist.




Stem Cell Treatment | CellMedicine.com



Ad
 ·
www.CellMedicine.com



Autism, CP, MS, Spinal Cord Injury and Arthritis SInce 2006





Multiple Sclerosis



Spinal Cord Injury



Autism



Rheumatoid Arthritis



Osteoarthritis




Results From The WOW.Com Content Network

Eye Drops Could Treat Age-Related Macular Degeneration ...

www.huffingtonpost.com/2013/10/15/eye-drops-macular-degeneration_n...


A drop a day might soon keep blindness away. Researchers say they have found a possible treatment for age-related macular degeneration (AMD) -- the leading ...


Emixustat hydrochloride - WOW.com

www.wow.com/wiki/Emixustat_hydrochloride


"Acucela inks development deal for two compounds". Fierce Biotech. Fierce Markets. Retrieved 30 March 2016. ...


RPE65 - WOW.com

www.wow.com/wiki/RPE65


acucela.com. Retrieved 2016-03-01. ... "RPE65, the major retinal pigment epithelium microsomal membrane protein, associates with phospholipid liposomes".


Thomas Reh - WOW.com

www.wow.com/wiki/Thomas_Reh


Thomas A. Reh Ph.D. is an American scientist and author. His research has been funded through numerous grants from the National Institutes of Health (NIH) and many ...


National Bureau of Asian Research - WOW.com

www.wow.com/wiki/National_Bureau_of_Asian_Research


The National Bureau of Asian Research (NBR) is an American nonprofit, research institution based in Seattle, Washington, with a branch office in Washington, D.C. The ...










Acucela Jobs - 2 Open Positions Left -- Apply Now!



Ad
 ·
Acucela-Jobs.jobsgalore.com/​



2 Open Positions Left -- Apply Now! Acucela Jobs





Receive Daily Job Alerts



Post a Job




About our Job Search



Find Your New Job





Shaklee Product Center | buy-products.myshaklee.com



Ad
 ·
http:/​/​buy-products.myshaklee.com



Your Online Source for Shaklee Products. Shaklee Dist.




Stem Cell Treatment | CellMedicine.com



Ad
 ·
www.CellMedicine.com



Autism, CP, MS, Spinal Cord Injury and Arthritis SInce 2006





Multiple Sclerosis



Spinal Cord Injury



Autism



Rheumatoid Arthritis



Osteoarthritis




Searches related toacucela



acucela careers


acucela stock quote


acucela ipo


acucela stock



acucela inc


acucela stock price


acucela bothell wa


acucela 4589






Related Searches



acucela careers


acucela stock quote


acucela ipo


acucela stock


acucela inc


acucela stock price


acucela bothell wa


acucela 4589




















Search the Web

















© AOL Inc. All Rights Reserved.Privacy
 | Terms of Use
 | Preferences
 | Contact Us
 | Powered by Bing™

Wow.com - Part of the AOL Search Network












Acucela Inc.





































ENGLISH
JAPANESE



HOME

VISION
PIPELINE
IR LIBRARY
COMPANY





FAQs
Contact Us
Privacy Policy
Terms of Use

© 2016 Acucela Inc.
























Acucela Inc. is committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide.





next







VISION
Learn about our vision of restoring sight for millions of people suffering from sight-threatening diseases and conditions.





more info







PIPELINE
Learn about our focus on ophthalmological innovation and breakthrough, and our diverse pipeline portfolio in development.





more info







IR LIBRARY
Access all of our financials and disclosures, as well as corporate presentations and news.





more info







COMPANY
Learn about our leadership team, corporate history and the company, including contact information.





more info













Acucela Inc. - Office in Seattle Central Business District


FoursquareLog InSign UpNearby:Get inspired:Top PicksTrendingFoodCoffeeNightlifeFunShoppingPlanning a trip to Seattle?Foursquare can help you find the best places to go to.Find great things to doAcucela Inc.OfficeSeattle Central Business District, SeattleSaveShareTipsPhotos 1Acucela Inc.No tips and reviewsLog in to leave a tip here.PostNo tips yetWrite a short note about what you liked, what to order, or other helpful advice for visitors.1 PhotoRelated Searchesacucela inc. seattle  acucela inc. seattle photos  acucela inc. seattle location  acucela inc. seattle address  acucela inc. seattle  acucela inc. seattle  acucela inc. seattle central business district seattleAboutBlogBusinessesCitiesDevelopersHelpJobsCookies (Updated)Privacy (Updated)TermsEnglishEnglish Français Deutsch Bahasa Indonesia Italiano 日本語 한국어 Português Русский Español ภาษาไทย Türkçe Cities:AtlantaAustinBostonChicagoDallasDenverHoustonLas VegasLos AngelesNew YorkPhiladelphiaPortlandSan DiegoSan FranciscoSeattleWashington, D.C.Countries:BelgiumBrazilCanadaChileFinlandFranceGermanyGreat BritainHungaryIndonesiaJapanMexicoNetherlandsPhilippinesRussiaSingaporeSpainThailandTurkeyMore Great Places in Seattle:abcdefghijklmnopqrstuvwxyz#Foursquare © 2017  Lovingly made in NYC & SFAcucela Inc.1301 2nd Ave Ste 1900Seattle, WA 98101United StatesGet directions See MoreUnited States » King County » Seattle » Seattle Central Business DistrictProfessional & Other Places » OfficeIs this your business? Claim it now.Make sure your information is up to date. Plus use our free tools to find new customers.You must enable JavaScript to use foursquare.comWe use the latest and greatest technology available to provide the best possible web experience.Please enable JavaScript in your browser settings to continue.Download Foursquare for your smart phone and start exploring the world around you!












Bing Places for Business
























































































































Bing
 places for business


Sign in using your




Microsoft Account





Work Account





Google Account





Facebook Account

Don't have an account? Create one.


